Emergent Biosolutions Inc. (EBS)

Last Closing Price: 4.74 (2025-05-07)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Emergent Biosolutions Inc. (EBS) had Net Income of $-31.30M for the most recently reported fiscal quarter, ending 2024-12-31.

Figures for fiscal quarter ending 2024-12-31
Income Statement Financials
$194.70M
Net Income
$-31.30M
$118.00M
$76.70M
$204.20M
$-9.50M
$-18.10M
$-27.60M
$-27.60M
$-31.30M
$-31.30M
$-31.30M
$-31.30M
$-9.50M
$18.70M
53.00M
53.00M
$-0.55
$-0.45
Balance Sheet Financials
$598.70M
$270.60M
$791.00M
$1.39B
$162.40M
$663.70M
$744.50M
$906.90M
$482.80M
$-18.70M
$482.80M
54.30M
Cash Flow Statement Financials
$58.70M
$125.20M
$-190.00M
$111.70M
$105.60M
$-6.10M
$18.00M
--
--
Fundamental Metrics & Ratios
3.69
--
--
0.58
1.37
39.39%
-4.88%
-4.88%
--
-14.18%
-16.08%
$43.70M
--
--
--
0.14
0.38
1.26
71.42
-6.48%
167.38%
-2.25%
-2.73%
$8.89
$0.82
$1.11